Soligenix extends patent protection for its filovirus vaccine platform to the UK and South Africa
Soligenix, a late-stage biopharmaceutical company, announced it has received notice of intent to grant additional patents based on its patent application titled "Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines" in the …